Product NDC: | 51079-138 |
Proprietary Name: | donepezil hydrochloride |
Non Proprietary Name: | DONEPEZIL HYDROCHLORIDE |
Active Ingredient(s): | 5 mg/1 & nbsp; DONEPEZIL HYDROCHLORIDE |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 51079-138 |
Labeler Name: | UDL Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021720 |
Marketing Category: | NDA |
Start Marketing Date: | 20110112 |
Package NDC: | 51079-138-56 |
Package Description: | 10 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-138-56) > 30 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (51079-138-30) |
NDC Code | 51079-138-56 |
Proprietary Name | donepezil hydrochloride |
Package Description | 10 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-138-56) > 30 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (51079-138-30) |
Product NDC | 51079-138 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | DONEPEZIL HYDROCHLORIDE |
Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
Route Name | ORAL |
Start Marketing Date | 20110112 |
Marketing Category Name | NDA |
Labeler Name | UDL Laboratories, Inc. |
Substance Name | DONEPEZIL HYDROCHLORIDE |
Strength Number | 5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |